Vanda Joins Schumacher for IndyCar | Nascar News

Vanda Pharmaceuticals makes its motorsports debut with a bold partnership, sponsoring Mick Schumacher’s 47 Rahal Letterman Lanigan Racing IndyCar for four key races—including Nashville, Portland, D.C., and Monterey—promoting its new motion sickness treatment, Nereus. The timing? Celebrating 47 years since the last U.S.-approved motion sickness drug, aligning perfectly with Schumacher’s car number. Vanda’s CEO and Rahal’s Jay Frye both see the deal as a powerful health awareness opportunity, especially at D.C., where they’ll reach fans with a vital wellness message. This sponsorship adds crucial momentum to Schumacher’s IndyCar journey, blending racing excitement with real-world health innovation. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/bc48ae5166191986